Join us in Boston!
November 2-4, 2011

Thank you to all of our speakers, sponsors, and exhibitors for your support and contribution, and to all the delegates for your participation.
The success of this event is largely due to the dedicated participants that return with us year after year.

If you would like to share your feedback, or give input for next year’s event, please contact Margit Eder at

Discovery on Target 2010

Concurrent Tracks | November 2-3, 2010 

HDAC Inhibitors

GPCR-Based Drug Discovery

Ion Channels as Therapeutic Targets

Targeting the P13K Pathway 

Concurrent Tracks | November 3-4, 2010 

RNAi for Functional Screens
The Challenge of Developing Kinase Inhibitors
Diabetes Drug Discovery
New Ways to Tackle COPD and Other Chronic Pulmonary Diseases 



Allosteric Modulators of GPCRs  

Structure-Based Design of Ion Channel – Linked Receptors   

Best Practices for Setting Up Effective RNAi Screens  

In vivo Discovery and Validation Using RNAi  

Assessing Cardio Safety of Diabetes Drug Candidates  

*Separate registration required. 


Edward Seto, Ph.D. 

Chairman, Department of Molecular Oncology, H. Lee Moffitt Cancer Center 

Gregory J. Kaczorowski, Ph.D. 

Adjunct Professor, Physiology and Pharmacology, New Jersey Medical School; Adjunct Professor, Physiology and Biophysics, Robert Wood Johnson Medical School 

Laszlo Kiss, Ph.D. 

Senior Research Fellow, Merck Research Laboratories 

Spyro Mousses, Ph.D. 

Vice President, Office of Innovation and Director, Center of BioIntelligence, Translational Genomics Research Institute 

Jorge Plutzky, M.D. 

Director, The Vascular Disease Prevention Program, Cardiovascular Division, Brigham and Women’s Hospital and Associate Professor, Harvard Medical School 

Thomas Sakmar, M.D. 

Professor, Molecular Biology and Biochemistry, Rockefeller University 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

2014 Discovery on Target Brochure  

 green arrow FINAL BROCHURE 



green arrow VIEW ALL SPONSORS 



The exhibit hall was sold out in 2013, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2014, contact:

Jon Stroup
Business Development Manager

2014 Discovery On Target CAG 



October 8 – 9

Targeting Epigenetic Readers and
Chromatin Remodelers

Targeting the Ubiquitin Proteasome System  

Big Data Analytics and Solutions  

GPCR-Based Drug Discovery  

RNAi for Functional Genomics Screening
– Part 1

Protein-Protein Interactions as Drug Targets  

Antibodies Against Membrane Protein Targets
– Part 1

October 9 – 10

Targeting Histone Methyltransferases and Demethylases  

Screening Drug Transporter Proteins  

Maximizing Efficiency in Discovery  

GPCR-Targeted Therapeutics  

Genome Editing for Functional Genomics
Screens – Part 2

Cancer Metabolism  

Antibodies Against Membrane Protein Targets
– Part 2


October 7

Next Generation Histone Deacetylase Inhibitors  


October 7

SC1: Designing Scalable Software Systems for Big Data Analytics  

SC2: Approaches for Biologically-Relevant Chemical Diversity  

SC3: Setting Up Effective RNAi Screens: From Design to Data to Validation  

SC4: Targeting Protein-Protein Interactions  

SC5: GPCR Structure-Based Drug Discovery  

SC6: Advances in Metagenomic Drug Discovery for New Anti-Infective Agents  

SC7: Targeting of GPCRs with Monoclonal Antibodies  

SC8: A Primer to Gene Editing: Tools and Applications  

SC9: Introduction to Targeted Covalent Inhibitors  

October 9

SC10: Setting Up Effective Functional Screens Using 3D Cell Cultures  

SC11: Integration of BDDCS and Extended Clearance Principles  

SC12: Introduction to Allosteric Modulators and Biased Ligands of GPCRs  

SC13: Introduction to Drug Metabolism